B96.83

Clinical Causes: Hospital-acquired infections, particularly in intensive care units (ICUs) Open wounds or surgical sites contaminated with *Acinetobacter baumannii* Invasive medical procedures that breach the skin barrier Prolonged use of ventilators or indwelling devices like catheters Compromised immune system, such as in patients with chronic illnesses or immunosuppressive therapies Exposure to contaminated hospital environments or equipment

Key Symptoms: Fever and chills Pneumonia symptoms such as cough, shortness of breath, and chest pain Wound redness, swelling, and pus Bloodstream infections leading to sepsis Urinary tract infections characterized by pain and difficulty urinating Other localized infections depending on the site of *Acinetobacter* colonization

Diagnosis Path: Diagnosing infections caused by *Acinetobacter baumannii* involves collecting samples from the suspected infection site, such as blood, sputum, urine, or wound swabs. These are then cultured in a laboratory to identify the bacteria. Further tests, including antibiotic susceptibility testing, help determine the most effective treatment options. Imaging studies may be used to assess complications such as pneumonia or abscesses. Accurate diagnosis is crucial for guiding appropriate therapy and managing the infection effectively.

Treatment Protocols: Treatment of *Acinetobacter baumannii* infections often involves a combination of antibiotic therapy tailored to the specific strain’s susceptibility profile. This may include drugs such as carbapenems, aminoglycosides, or polymyxins. Because *Acinetobacter* can be resistant to multiple antibiotics, multidrug-resistant strains require complex treatment strategies. Supportive care, such as respiratory support for pneumonia or wound management, may also be necessary. Infection control measures are vital to prevent the spread within healthcare settings. It is important for healthcare providers to monitor treatment responses and adjust therapies accordingly.